Avatar Medical Vision
Avatar Medical · Decision date Mar 30, 2026
What did the FDA decide?
FDA records K253950 as a 510(k) premarket notification, with a decision dated Mar 30, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Mar 30, 2026
Regulatory record facts
- Identifier
- K253950
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Avatar Medical
- Product code
- LLZ
- Decision code
- SESE
- Decision date
- Mar 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, Image Processing, Radiological.
- Applicant
- Avatar Medical
- Product code
- LLZ
- FDA device class
- 2
FDA decision timeline
K253950 received
Application receipt date recorded by FDA.
K253950 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code LLZ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
3D Anatomical ModelK262132 | The Jacobs Institute | 510(k) clearance | Nov 5, 2026 | FDA |
LiLi DICOM Viewer (LiLi )K260454 | Elevate Imaging, Inc. | 510(k) clearance | Nov 4, 2026 | FDA |
| Canon Medical Informatics, Inc. | 510(k) clearance | Oct 29, 2026 | FDA | |
MIM KineticIDK261763 | Mim Software, Inc. | 510(k) clearance | Oct 26, 2026 | FDA |
PV-iCurve ProK261531 | Perception Vision Medical Technology Co., Ltd. | 510(k) clearance | Oct 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Avatar Medical
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Paris
Sources and methodology
- Original FDA record: K253950
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


